Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Synthetic phosphatidylinositol phosphate (PtdIns ) derivatives play a pivotal role in broadening our understanding of PtdIns metabolism. However, the development of such tools is reliant on efficient enantioselective and regioselective synthetic strategies. Here we report the development of a divergent synthetic route applicable to the synthesis of deuterated PtdIns4 and PtdIns5 derivatives. The synthetic strategy developed involves a key enzymatic desymmetrisation step using Lipozyme TL-IM®. In addition, we optimised the large-scale synthesis of deuterated -inositol, allowing for the preparation of a series of saturated and unsaturated deuterated PtdIns4 and PtdIns5 derivatives. Experiments in MCF7 cells demonstrated that these deuterated probes enable quantification of the corresponding endogenous phospholipids in a cellular setting. Overall, these deuterated probes will be powerful tools to help improve our understanding of the role played by PtdIns in physiology and disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607509PMC
http://dx.doi.org/10.1039/d0sc06219gDOI Listing

Publication Analysis

Top Keywords

synthesis deuterated
8
deuterated ptdins4
8
ptdins4 ptdins5
8
ptdins5 derivatives
8
deuterated probes
8
deuterated
5
development isotope-enriched
4
isotope-enriched phosphatidylinositol-4-
4
phosphatidylinositol-4- 5-phosphate
4
5-phosphate cellular
4

Similar Publications

Asymmetric catalytic synthesis of chiral deuterated compounds.

Chem Commun (Camb)

September 2025

International Joint Research Centre for Molecular Science, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, 518060, P. R. China.

Deuterated compounds possess significant research value. As interest in chiral deuterated compounds intensifies, various deuteration methods are garnering increased attention. This article primarily reviews the asymmetric deuterium synthesis methods reported in recent years, focusing on the following strategies: one-step reductive deuteration, the series reaction of H/D exchange and asymmetric allylation, the [3+2] asymmetric cycloaddition of 1,3-dipoles and alkenes, asymmetric deuteration photocatalysis, asymmetric deuteration using organic catalysis, and asymmetric deuteration of chiral amino acids and their derivatives through biocatalysis.

View Article and Find Full Text PDF

Irsenontrine is a novel phosphodiesterase-9 inhibitor that has been developed for the treatment of cognitive dysfunction. To assess the pharmacokinetics, excretion, and distribution of the drug in humans, comprehensive assays for irsenontrine were developed using liquid chromatography with tandem mass spectrometry (LC-MS/MS) in three human matrices, including plasma, urine, and cerebrospinal fluid (CSF). Irsenontrine was extracted from the matrices by a straightforward protein precipitation method and subsequently separated on a reverse-phase column.

View Article and Find Full Text PDF

To address the low biotransformation efficiency and high interindividual variability of clopidogrel (Clop), we developed a novel deuterated Clop-ferulic acid derivative (Dclop-FA), featuring an FA ester pharmacophore at the C2 and a deuterated methyl ester at the C7 position. Pharmacokinetic studies in rats showed that a single oral dose of Dclop-FA achieved 6.0-fold greater systemic exposure to the active metabolite versus equimolar coadministration of Clop and FA.

View Article and Find Full Text PDF

Probing Intracellular Yeast Metabolism With Deuterium Magnetic Resonance Spectroscopy.

NMR Biomed

October 2025

Section Biomedical Imaging, Molecular Imaging North Competence Center, Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany.

Metabolomics provides snapshots of states of metabolites under specific conditions, with nuclear magnetic resonance (NMR) being one of the few noninvasive techniques. However, when applied to intact cells (e.g.

View Article and Find Full Text PDF

Investigation of the earliest stages of hydrothermal reactions between KRuO and either Sr(NO) or SrO allows the isolation of phase-pure SrRuO(OH), a hitherto uncharacterized Ru(VI) oxyhydroxide, previously mentioned in the literature as SrRuO·HO. Further exploration of synthesis conditions with excess of strontium salt yields a second Ru(VI) phase, SrRuO(OH) at 200 °C. Both structures were solved by 3D-electron diffraction and refined using powder neutron diffraction (SrRuO(OH): monoclinic 2/, = 9.

View Article and Find Full Text PDF